Effect of T-Type Selective Calcium Antagonist on Renal Microcirculation: Studies in the Isolated Perfused Hydronephrotic Kidney
暂无分享,去创建一个
[1] Haruko Masumiya,et al. Inhibition of T-Type and L-Type Ca2+ Currents by Aranidipine, a Novel Dihydropyridine Ca2+ Antagonist , 2000, Pharmacology.
[2] T. Saruta,et al. Distinct action of aranidipine and its active metabolite on renal arterioles, with special reference to renal protection. , 2000, Journal of cardiovascular pharmacology.
[3] G. Molderings,et al. N-Type calcium channels control sympathetic neurotransmission in human heart atrium. , 2000, Circulation.
[4] T. Saruta,et al. Role of protein kinase C in angiotensin II-induced constriction of renal microvessels. , 2000, Kidney international.
[5] J. Ménard,et al. Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats. , 1999, Hypertension.
[6] T. Olsson. Activity in the Hypothalamic-Pituitary- Adrenal Axis and Delirium , 1999, Dementia and Geriatric Cognitive Disorders.
[7] E. Frohlich,et al. Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats. , 1999, Hypertension.
[8] T. Saruta,et al. Renal afferent and efferent arteriolar dilation by nilvadipine: studies in the isolated perfused hydronephrotic kidney. , 1999, Journal of cardiovascular pharmacology.
[9] N. Akaike,et al. Effect of nilvadipine on the voltage-dependent Ca2+ channels in rat hippocampal CA1 pyramidal neurons , 1998, Brain Research.
[10] H. Masumiya,et al. Inhibition of myocardial L- and T-type Ca2+ currents by efonidipine: possible mechanism for its chronotropic effect. , 1998, European journal of pharmacology.
[11] F. Werf,et al. T‐type Ca2+ current as a trigger for Ca2+ release from the sarcoplasmic reticulum in guinea‐pig ventricular myocytes , 1998, The Journal of physiology.
[12] T. Saruta,et al. Renal protective effects of efonidipine in partially nephrectomized spontaneously hypertensive rats. , 1998, Clinical and experimental hypertension.
[13] A. Dendorfer,et al. Interactions between the renin-angiotensin system (RAS) and the sympathetic system , 1998, Basic Research in Cardiology.
[14] T. Saruta,et al. Cellular mechanisms mediating rat renal microvascular constriction by angiotensin II. , 1997, The Journal of clinical investigation.
[15] K. Abe,et al. Diverse effects of calcium antagonists on glomerular hemodynamics. , 1996, Kidney international. Supplement.
[16] K. Hermsmeyer,et al. Protein kinase C mechanism enhances vascular muscle relaxation by the Ca2+ antagonist, Ro 40-5967. , 1996, Journal of vascular research.
[17] T. Saruta,et al. Disparate effects of calcium antagonists on renal microcirculation. , 1996, Hypertension research : official journal of the Japanese Society of Hypertension.
[18] R. Loutzenhiser,et al. Divergent mechanisms of ATP-sensitive K+ channel-induced vasodilation in renal afferent and efferent arterioles. Evidence of L-type Ca2+ channel-dependent and -independent actions of pinacidil. , 1995, Circulation research.
[19] R. Tsien,et al. Voltage-dependent blockade of diverse types of voltage-gated Ca2+ channels expressed in Xenopus oocytes by the Ca2+ channel antagonist mibefradil (Ro 40-5967). , 1995, Molecular pharmacology.
[20] F. Bühler,et al. Mibefradil prevents neointima formation after vascular injury in rats. Possible role of the blockade of the T-type voltage-operated calcium channel. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[21] S. Mishra,et al. Selective inhibition of T-type Ca2+ channels by Ro 40-5967. , 1994, Circulation research.
[22] Y. Furuichi,et al. Effect of Nilvadipine on the Development of Neurological Deficits in Stroke‐Prone Spontaneously Hypertensive Rats , 1994, Stroke.
[23] P. Carmines,et al. Segmentally distinct effects of depolarization on intracellular [Ca2+] in renal arterioles. , 1993, The American journal of physiology.
[24] F. Marumo,et al. Endothelin-1 enhances calcium entry through T-type calcium channels in cultured neonatal rat ventricular myocytes. , 1992, Circulation research.
[25] M. Epstein. Calcium Antagonists in Clinical Medicine , 1992 .
[26] S. Tanaka,et al. Effects of NZ‐105, a New Calcium Antagonist, on Renal Function in Anesthetized Spontaneously Hypertensive Rats , 1992, Journal of cardiovascular pharmacology.
[27] M. Epstein,et al. Pressure-Induced Vasoconstriction of Renal Microvessels in Normotensive and Hypertensive Rats: Studies in the Isolated Perfused Hydronephrotic Kidney , 1989, Circulation research.
[28] M. Epstein,et al. Effects of amlodipine on renal hemodynamics. , 1989, The American journal of cardiology.
[29] M. Epstein,et al. Divergent effects of KCl-induced depolarization on afferent and efferent arterioles. , 1989, The American journal of physiology.
[30] L. Navar,et al. Disparate effects of Ca channel blockade on afferent and efferent arteriolar responses to ANG II. , 1989, The American journal of physiology.
[31] M. Epstein,et al. Renal hemodynamic effects of calcium antagonists. , 1987, American Journal of Cardiology.
[32] M. Epstein,et al. Atrial natriuretic peptide reverses afferent arteriolar vasoconstriction and potentiates efferent arteriolar vasoconstriction in the isolated perfused rat kidney. , 1988, The Journal of pharmacology and experimental therapeutics.
[33] M. Steinhausen,et al. Vasomotion and Vasoconstriction Induced by a Ca++-Agonist in the Split Hydronephrotic Kidney , 1988 .
[34] M. Epstein,et al. Renal hemodynamic effects of calcium antagonists. , 1987, Journal of cardiovascular pharmacology.
[35] J. Fleming,et al. Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney. , 1987, The American journal of physiology.
[36] R. Loutzenhiser,et al. Characterization of the Renin-Angiotensin System in the Isolated Perfused Rat Kidney , 1979 .
[37] J. Grosswendt,et al. [Effect of BAY a 1040 on renal function in hypertension]. , 1972, Arzneimittel-Forschung.